Peter Lio, MD, spoke with The Dermatologist about concerns related to patients with atopic dermatitis, the transition to telemedicine in his practice, and what providers need to know as the COVID-19 pandemic evolves.
A murine model showed success in treating atopic dermatitis by activating natural killer cells instead of suppressing the immune response. The Dermatologist spoke with researcher Brian S. Kim, MD, about the future of this immunotherapeutic strategy.
Findings from a recent study showed patients with chronic inflammatory skin diseases had an increased risk for herpes zoster. Jonathan I. Silverberg, MD, PhD, MPH, discussed these findings with The Dermatologist.
Genetic polymorphisms and defects are commonly found in patients with atopic dermatitis. A more personalized therapy that considers individual genetics and pathogenesis may provide a more effective treatment approach.
Children with eczema and their parents are often at wits’ end with alleviating the itch associated with atopic dermatitis. Perhaps it is time to shift the paradigm from “stop scratching” to alternative or behavioral health approaches to fight itch with less mental anguish.
Patients who present with atopic dermatitis often desire treatment of associated cosmetic concerns. Dermatologists should familiarize themselves with these tools for treating skin pigmentary and texture changes.